Sharesight is an online portfolio-tracking tool that lets you sync and view all your investment accounts in a single platform. In addition to tracking your portfolio performance, you can keep track of ...

Monthly dividend stocks offer something most income investments cannot: a paycheck every single month. For investors building passive income, that cadence matters. But with the 10-year Treasury ...

Recent market volatility triggered by the Iran war has created sharp pullbacks in two high-quality dividend growth stocks, ...

I rate Schwab U.S. Dividend Equity ETF (SCHD) a buy and State Street® SPDR® S&P® Dividend ETF (SDY) a hold, favoring SCHD’s quality-driven strategy. SCHD offers higher dividend yield (3.80%), lower ...

Investors can evaluate a company's dividend by looking at its track record, earnings, and free cash flow. While not super common, there are safe high-yielding dividends to be found. These companies ...

Explore how sector focus and portfolio structure set these two dividend ETFs apart for income-minded investors.

Abbott Laboratories (ABT) raised its quarterly dividend to $0.63 with a 60.4% free cash flow payout ratio. Abbott’s FreeStyle Libre faces a Class I recall after 860 serious injuries and 7 deaths.

Visa and Novartis have strong dividend track records and attractive long-term outlooks. Meta Platforms initiated a dividend two years ago, adding appeal to its already strong growth prospects.

The Schwab US Dividend Equity ETF (SCHD) has accumulated over $83 billion in assets, making it one of the biggest dividend ...